IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lynx1 Capital Management LP

Q2 2022 Holdings

Filed 2022-08-15 | 12 holdings | $117.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Bellus Health Inc New(BLU)COM NEW07987C204$26.2K2,831,58822.3%
Merus N VCOMN5749R100$22.7K1,001,21719.3%
Kinnate Biopharma IncCOM49705R105$21.1K1,674,67718.0%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$16.4K1,926,86914.0%
Cymabay Therapeutics Inc(CBAYUSD)COM23257D103$7.6K2,589,6796.5%
Pardes Biosciences IncCOM69945Q105$6.7K2,180,5605.7%
Pieris Pharmaceuticals IncCOM720795103$6.0K3,223,3345.1%
Immunic Inc(IMUX)COM4525EP101$3.8K1,104,2413.3%
Aerovate Therapeutics IncCOM008064107$3.0K191,5652.6%
Theseus Pharmaceuticals IncCOM88369M101$2.8K504,8622.4%
Passage BIO IncCOM702712100$995421,4100.8%
Otonomy IncCOM68906L105$6230,0000.1%